BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 12802468)

  • 1. [Reimbursement of the PET in oncology in Europe: a questionnaire based survey].
    Dietlein M; Schicha H
    Nuklearmedizin; 2003 Jun; 42(3):80-5. PubMed ID: 12802468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical PET activities in European and Asia-Oceanian countries].
    Tashiro M; Kubota K; Ito M; Fujimoto T; Yamaguchi K; Sasaki H; Moser E
    Kaku Igaku; 2001 May; 38(3):255-67. PubMed ID: 11452493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic analyses on the use of positron emission tomography for the work-up of solitary pulmonary nodules and for staging patients with non-small-cell-lung-cancer in Italy.
    Gugiatti A; Grimaldi A; Rossetti C; Lucignani G; De Marchis D; Borgonovi E; Fazio F
    Q J Nucl Med Mol Imaging; 2004 Mar; 48(1):49-61. PubMed ID: 15195004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reimbursement for tissue reconstruction by pedicled and free flaps across five European countries. The importance of autologous breast reconstruction.
    Lotter O; Stahl S; Townley WA; Hoefert S; Eberhard Schaller H; Amr A
    Minerva Chir; 2013 Apr; 68(2):129-37. PubMed ID: 23612226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Present status of PET images: clinical FDG PET in oncology].
    Inoue T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1999 Nov; 59(13):737-44. PubMed ID: 10614103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Understanding positon emission tomography (PET) with [18F]-FDG in clinical oncology. Informations dedicated to patients and relatives].
    Bourguet P; Brusco S; Corone C; Devillers A; Foehrenbach H; Lumbroso JD; Maszelin P; Montravers F; Moretti JL; Rain JD; Talbot JN; Carretier J; Leichtnam-Dugarin L; Delavigne V; Philip T; Fervers B; ; ; ; ; ; ;
    Bull Cancer; 2005 Jul; 92(7):723-32. PubMed ID: 16123010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Positron emission tomography (PET) in oncology: a part of medical therapeutic expertise].
    Bamberg M; Diehl V; Herrmann T; Jürgens H; Siewert JR; Kotzerke J;
    Dtsch Med Wochenschr; 2006 Mar; 131(10):512-5. PubMed ID: 16511743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Positron emission tomography (PET) and (F-18)-fluorodeoxyglucose in (FDG) in cancerology].
    Maublant J; Vuillez JP; Talbot JN; Lumbroso J; Muratet JP; Herry JY; Artus JC
    Bull Cancer; 1998 Nov; 85(11):935-50. PubMed ID: 9951421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical usefulness of FDG-PET in oncology].
    Sasaki M
    Nihon Igaku Hoshasen Gakkai Zasshi; 2001 Jul; 61(8):414-20. PubMed ID: 11524817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient access to voice prostheses and heat and moisture exchangers: Factors influencing physician's prescription and reimbursement in eight European countries.
    Beck ACC; Retèl VP; van den Brekel MWM; van Harten WH
    Oral Oncol; 2019 Apr; 91():56-64. PubMed ID: 30926063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis-Related Groups in Hand Surgery--a comparison of six European countries.
    Lotter O; Amr A; Chiarello P; Bihler M; Schaller HE; Stahl S
    Ger Med Sci; 2012; 10():Doc08. PubMed ID: 22557941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical value of positron emission tomography (PET) in oncologic questions: results of an interdisciplinary consensus conference. Schirmerreschaft der Deutschen Gesellschaft for Nuklearmedizin].
    Reske SN; Bares R; Büll U; Guhlmann A; Moser E; Wannenmacher MF
    Nuklearmedizin; 1996 Apr; 35(2):42-52. PubMed ID: 8721575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Positron emission tomography in the Netherlands: need to expand the capacity].
    Comans EF; Smit EF
    Ned Tijdschr Geneeskd; 2002 Sep; 146(39):1817-9. PubMed ID: 12382364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positron tomography: the case for reimbursement.
    Coleman RE
    Appl Radiol; 1989 Sep; 18(9):39-45, 48. PubMed ID: 10304419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Availability of antiepileptic drugs across Europe.
    Baftiu A; Johannessen Landmark C; Nikaj V; Neslein IL; Johannessen SI; Perucca E
    Epilepsia; 2015 Dec; 56(12):e191-7. PubMed ID: 26477534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical application of FDG-PET for cancer diagnosis].
    Nakamoto Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 2003 Jul; 63(6):285-93. PubMed ID: 12934545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FDG-PET for clinical use. Results of the 3rd German Interdisciplinary Consensus Conference, "Onko-PET III", 21 July and 19 September 2000.
    Reske SN; Kotzerke J
    Eur J Nucl Med; 2001 Nov; 28(11):1707-23. PubMed ID: 11702115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pet projects.
    Sanders B
    Radiol Manage; 2002; 24(4):48-50. PubMed ID: 12229057
    [No Abstract]   [Full Text] [Related]  

  • 19. New indications give PET a lift after struggle over regulatory and reimbursement issues.
    Conti PS; Keppler J
    Diagn Imaging (San Franc); 2000 Jan; 22(1):40-7. PubMed ID: 10848425
    [No Abstract]   [Full Text] [Related]  

  • 20. Implementation of PET scan as a new service.
    Stanfill P; Weber D
    J Oncol Manag; 2002; 11(1):11-4. PubMed ID: 11858325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.